Musculoskeletal Research Laboratory of Department of Orthopaedics and Traumatology and Innovative Orthopaedic Biomaterial and Drug Translational Research Laboratory, Li Ka Shing Institute of Health, Faculty of Medicine, CUHK, Hong Kong Special Administrative Region, PR China.
Department of Anaesthesia and Intensive Care, Faculty of Medicine, CUHK, Hong Kong Special Administrative Region, PR China.
Spine J. 2018 Nov;18(11):2112-2118. doi: 10.1016/j.spinee.2018.06.354. Epub 2018 Jun 30.
Cervical radicular pain resulting from mechanical compression of a spinal nerve secondary to spinal degenerative alternations negatively impacts patients' quality of life. Jingshu Keli (JSKL), a traditional Chinese medicine formula with multiple active compounds, has been prescribed for pain management in patients with cervical radiculopathy for decades. Two major components of JSKL, ferulic acid and cinnamaldehyde, were identified to have anti-inflammation effect via inhibiting activation of Stat3.
To investigate the efficacy of JSKL by investigating its mechanism in attenuating cervical radiculopathy-induced mechanical allodynia via modulation activation of spinal microglia and phosphorylation of signal transducer and activator of transcription 3 (Stat3).
An in vivo animal experiment.
Cervical radiculopathy of rats was established by C7 spinal nerve ligation (SNL) with 6-0 silk suture. The effect of postoperational daily gavage of JSKL on mechanical allodynia of rats was tested on day 3, 7, and 14 after surgery. Furthermore, spinal glial cells activation and phosphorylation of Stat3 (p-Stat3) were tested with immunofluorescence imaging and Western blot.
The JSKL significantly inhibited SNL-induced allodynia as well as microglia activation in the spinal cord on day 7 and 14 after surgery. Moreover, expression of p-Stat3 was decreased in rats with SNL and JSKL treatment in comparison with rats with SNL and vehicle treatment.
The JSKL attenuated SNL-induced mechanical allodynia in rats. This analgesic effect might be explained by the suppression of activations of spinal microglia as well as p-Stat3. Our study provides experimental evidence for JSKL as an alternative approach to manage refractory pain in patients with cervical radiculopathy.
由于脊柱退行性改变导致的脊神经根受压而引起的颈根性疼痛,会降低患者的生活质量。颈舒颗粒(JSKL)是一种含有多种活性化合物的中药配方,几十年来一直被用于治疗颈神经根病患者的疼痛管理。JSKL 的两种主要成分,阿魏酸和肉桂醛,被确定具有通过抑制 Stat3 的激活来发挥抗炎作用。
通过研究其在通过调节脊髓小胶质细胞的激活和信号转导和转录激活因子 3(Stat3)的磷酸化来减轻颈神经根病引起的机械性痛觉过敏的机制,来研究 JSKL 的疗效。
体内动物实验。
用 6-0 丝线结扎 C7 脊神经(SNL)建立大鼠颈神经根病模型。手术后第 3、7 和 14 天,通过术后每日灌胃 JSKL 来测试其对大鼠机械性痛觉过敏的影响。此外,通过免疫荧光成像和 Western blot 测试脊髓神经胶质细胞的激活和 Stat3 的磷酸化(p-Stat3)。
JSKL 显著抑制了手术后第 7 天和第 14 天的 SNL 诱导的痛觉过敏以及脊髓中的小胶质细胞激活。此外,与 SNL 和载体处理的大鼠相比,SNL 和 JSKL 治疗的大鼠中 p-Stat3 的表达降低。
JSKL 减轻了大鼠的 SNL 诱导的机械性痛觉过敏。这种镇痛作用可能是通过抑制脊髓小胶质细胞的激活以及 p-Stat3 来解释的。我们的研究为 JSKL 作为治疗颈神经根病患者难治性疼痛的替代方法提供了实验证据。